Concept of venous thromboembolism prophylaxis following endovenous thermal procedures for chronic venous disease of the lower limbs
DOI:
https://doi.org/10.14739/2310-1210.2026.3.348582Keywords:
chronic venous disease, thermal treatment methods, radiofrequency ablation, endovenous laser coagulation, venous thromboembolism, EHIT, prophylaxisAbstract
Aim. To enhance the safety and efficacy of thermal ablation procedures in patients with chronic venous disease (CVD) of the lower limbs by developing a strategy for venous thromboembolism (VTE) prevention.
Materials and methods. This single-center, prospective, open-label study included 420 consecutive patients with CVD (C2–C6). Participants underwent radiofrequency ablation (RFA, n = 206) or endovenous laser ablation (EVLA, n = 214). At the first stage, VTE risk stratification was conducted using the Caprini scale; at the second stage, the optimal thromboprophylaxis algorithm was selected. Patients were divided into two homogeneous groups. Group 1 (208 patients) received VTE prevention with standard elastic compression only, while Group 2 (212 patients) received prophylaxis based on the proposed algorithm. The incidence of postoperative VTE and bleeding complications was assessed.
Results. According to VTE risk stratification, 23.6 % of patients were classified as low risk, 63.1 % as moderate risk, 9.0 % as high risk, 3.1 % as very high risk, and 1.2 % as the highest risk. Based on the second phase analysis, 12 patients (2.9 %) of Group 1 developed thrombotic complications during the early postoperative period: EHIT class II was diagnosed in 3 cases (0.7 %) after EVLA and in 2 cases (0.5 %) after RFA. Additionally, distal deep vein thrombosis (DVT) was detected in 7 patients (1.7 %) with high VTE risk on postoperative day 7: 3 after EVLA and 4 after RFA. Implementation of the proposed thromboprophylaxis strategy significantly reduced the total incidence of thrombotic complications compared to Group 1 (0.4 % vs. 2.9 %; p = 0.031). In Group 2, only one patient (0.4 %) with moderate VTE risk was diagnosed with distal DVT. Among 39 patients (18.3 %) who received prophylactic acetylsalicylic acid or rivaroxaban, a statistically significant increase in ecchymosis occurrence was observed (p = 0.018).
Conclusions. Implementing a differentiated, risk-oriented thromboprophylaxis strategy significantly (p = 0.031) reduced the incidence of VTE from 2.9 % to 0.4 %, p = 0.031, without increasing the risk of clinically significant bleeding.
References
- De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022;63(2):184-267. doi: https://doi.org/10.1016/j.ejvs.2021.12.024
|
|
- Gloviczki P, Lawrence PF, Wasan SM, Meissner MH, Almeida J, Brown KR, et al. The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine. J Vasc Surg Venous Lymphat Disord. 2024;12(1):101670. doi: https://doi.org/10.1016/j.jvsv.2023.08.011
|
|
- Dattani N, Shalhoub J, Nandhra S, Lane T, Abu-Own A, Elbasty A, et al. Reducing the risk of venous thromboembolism following superficial endovenous treatment: A UK and Republic of Ireland consensus study. Phlebology. 2020;35(9):706-14. doi: https://doi.org/10.1177/0268355520936420
|
|
- Wołkowski K, Wołkowski M, Urbanek T. Venous Thromboembolism Prophylaxis and Thrombotic Risk Stratification in the Varicose Veins Surgery-Prospective Observational Study. J Clin Med. 2020;9(12):3970. doi: https://doi.org/10.3390/jcm9123970
|
|
- Balachandran R, Jensen KK, Burcharth J, Ekeloef S, Schack AE, Gögenur I. Incidence of Venous Thromboembolism Following Major Emergency Abdominal Surgery. World J Surg. 2020;44(3):704-10. doi: https://doi.org/10.1007/s00268-019-05246-x
|
|
- Henry ML, Abdul-Sultan A, Walker AJ, West J, Humes DJ. Duration and Magnitude of Postoperative Risk of Venous Thromboembolism after Cholecystectomy: A Population-Based Cohort Study. Dig Surg. 2020;37(1):32-8. doi: https://doi.org/10.1159/000496435
|
|
- Turner B, Machin M, Jasionowska S, Salim S, Onida S, Shalhoub J, et al. Systematic Review and Meta-analysis of the Additional Benefit of Pharmacological Thromboprophylaxis for Endovenous Varicose Vein Interventions. Ann Surg. 2023;278(2):166-71. doi: https://doi.org/10.1097/SLA.0000000000005709
|
|
- Samama CM, Afshari A; ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis. Eur J Anaesthesiol. 2018;35(2):73-76. doi: https://doi.org/10.1097/EJA.0000000000000702
|
|
- Whittley S, Machin M, Burgess L, Onida S, Carradice D, Davies AH. Thromboprophylaxis strategies in patients undergoing endovenous thermal ablation: a UK survey. JVSGBI. 2023;3:26-31. doi: https://doi.org/10.54522/jvsgbi.2023.096
- Boyle E, Reid J, O'Donnell M, Harkin D, Badger S. Thromboprophylaxis for varicose vein procedures - A national survey. Phlebology. 2019;34(9):598-603. doi: https://doi.org/10.1177/0268355519828931
|
|
- Ribeiro AJ, Mendes-Pinto D, Erzinger FL, Fiorelli R, Fiorelli S, Ribeiro A, Marques MA. Thromboprophylaxis in lower limb varicose vein surgery in Brazil. J Vasc Bras. 2022;21:e20210172. doi: https://doi.org/10.1590/1677-5449.202101721
|
|
- Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism [Internet]. NICE. [cited 2025 Feb 9]. Available from: https://www.nice.org.uk/guidance/ng89/chapter/Recommendations
- Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248-52. doi: https://doi.org/10.1016/j.jvs.2004.09.027
|
|
- Atamaniuk OY, Skrypko VD, Atamaniuk VM. Radiofrequency ablation as a method of choice for the treatment of lower extremity varicose veins disease. Modern Medical Technology. 2023;(2):27-33. doi: https://doi.org/10.34287/mmt.2(57).2023.5
- How to assess DVT risk [Internet]. Caprini Rsk Score - Venous Resource Center. 2025 [cited 2026 Feb 4]. Available from: https://capriniriskscore.org/
- Grill MH, Caffaro RA, Grill TA, Júnior VC, Kikuchi R, Ribeiro CM, et al. A Prospective Study Evaluating Patterns of Responses to the Caprini Score to Prevent Venous Thromboembolism After Interventional Treatment for Varicose Veins. Clin Appl Thromb Hemost. 2022;28:10760296221112081. doi: https://doi.org/10.1177/10760296221112081
|
|
- Toth S, Flohr TR, Schubart J, Knehans A, Castello MC, Aziz F. A meta-analysis and systematic review of venous thromboembolism prophylaxis in patients undergoing vascular surgery procedures. J Vasc Surg Venous Lymphat Disord. 2020;8(5):869-881.e2. doi: https://doi.org/10.1016/j.jvsv.2020.03.017
|
|
- Moreira H, Sousa J, Mansilha A. Chemothromboprophylaxis in varicose vein surgery: a systematic review. Int Angiol. 2022;41(4):346-55. doi: https://doi.org/10.23736/S0392-9590.22.04908-2
|
|
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 O. Yu. Atamaniuk, V. D. Skrypko, S. V. Fedorov, V. M. Atamaniuk

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. 



